Therapeutic Apheresis Services

Our Therapeutic Apheresis Services Division provides advanced treatments for a wide range of complex medical conditions. Using state-of-the-art technology, we offer evidence-based procedures, including therapeutic plasma exchange (TPE) and other specialised apheresis therapies, all delivered by our highly trained medical team. Working collaboratively with specialities such as neurology, haematology, nephrology, dermatology, intensive care, and rheumatology, we are committed to delivering exceptional patient care guided by internationally recognised protocols.

Why choose SSMC?

With a strong focus on collaboration and innovation, our services are designed to support patients through every step of their healthcare journey. By leveraging state-of-the-art technology and a highly skilled multidisciplinary team, we strive to address diverse medical needs with precision and expertise. These key attributes highlight the excellence of our Therapeutic Apheresis Services Division:

Delivery of evidence-based treatments guided by the American Society for Apheresis (ASFA) guidelines and recommendations.
Comprehensive apheresis services tailored for both urgent and chronic cases.
Expert management of complex medical conditions requiring specialised apheresis care.
Capability to manage both emergency and scheduled outpatient procedures around the clock (24/7).
A highly skilled medical team trained in a wide range of apheresis modalities.
Treatment protocols strictly aligned with internationally recognised standards.
Real-time monitoring combined with personalised patient care and meticulous follow-up.

What We Treat

Neurological disorders - Guillain-Barré, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Myasthenia Gravis
Haematological conditions - Thrombotic Thrombocytopenic Purpura (TTP), Hyper-viscosity
Transplant medicine - Rejection, ABO Incompatibility
Renal diseases – Goodpasture Syndrome (anti-GBM disease), Anti-neutrophil Cytoplasmic Autoantibody (ANCA)-associated Vasculitis
Critical care conditions - Wilson Disease, Thyroid Storm
Sickle cell disease
Graft-versus-Host Disease
Cutaneous T-Cell Lymphoma
Solid organ transplant rejection
Systemic sclerosis
Hyperleukocytosis
Leukaemia
Symptomatic thrombocytosis
Essential thrombocythemia
Secondary thrombocytosis
Myeloproliferative disorders
Extreme thrombocytosis
Antibody-mediated disorders
Transplant rejection
Autoimmune conditions

Therapeutic Plasma Exchange (TPE)
Red Blood Cell Exchange
Extracorporeal Photopheresis (ECP)
Leukocytapheresis
Thrombocytapheresis
Platelet Depletion
Immunoadsorption
LDL Apheresis and Lipoprotein A Removal

Therapeutic Apheresis Services